MedPath

A clinical trail of Ayurvedic therapy in management of painful menses

Phase 2
Not yet recruiting
Conditions
Primary dysmenorrhea. Ayurveda Condition: UDAVARTAH,
Registration Number
CTRI/2022/07/044092
Lead Sponsor
NATIONAL INSTITUTE OF AYURVEDA
Brief Summary

Menstruation is normal vaginal bleeding that happens as part of woman’s monthly menstrual cycle. Dysmenorrhea is the condition of painful menstrual periods or menstrual discharge associated with pain. It is seen commonly in teenage girls and in young women. Dysmenorrhea is seen with mild to moderate intensity, and in up to 20% of women it may be severe enough to interfere with daily activities. The pain is most often manifests as menstrual cramps, like a throbbing pain or cramping pain in lower abdomen. It may also be associated with low-back pain, pain in thighs, leg pains, nausea, vomiting, diarrhea etc. It is commonly divided into primary dysmenorrhea and secondary dysmenorrhea. In Primary dysmenorrhoea pain occurs without any organic pathology and initial onset takes place usually 6-12 months after menarche, when ovulatory cycles are established. Pain duration is commonly 8 to 72 hours and is usually associated with the onset of menstrual flow.

**NULL HYPOTHESIS [H0]**

There is no difference in Oral administration*of Hinguvadi gutika*and*Rajahpravartani vati* in managing the *Udavarta Yonivyapad*with special reference to Primary dysmenorrhea.

**ALTERNATIVE  HYPOTHESIS [H1]**

There is difference between in *Hinguvadi* *gutika* and        *Rajahpravartavi* *vati* in managing the *Udavarta Yonivyapad*with special reference to Primary dysmenorrhea.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • PATIENTS WITH CHIEF COMPLAINT OF PAIN DURING MENSES ALONG WITH ASSOCIATED SYMPTOMS.
  • PATIENTS WHO HAVE MENSTRUAL PAIN SCORE MORE THAN GRADE I ACCORDING TO VERBAL MULTIDIMENSIONAL SCORING SYSTEM (VMSS).
  • PATIENTS WHO HAD REGULAR MENSTRAL CYCLES OF 23-35 DAYS IN THE LAST 3 MONTHS.
  • PATIENT IN AGE GROUP OF 18 TO 30 YEARS 5.
  • PATIENTS WITH H/O USING ANALGESICS DURING MENSES.
  • PATIENT WILLING TO GIVE VOLUNTARY INFORMED CONSENT FOR THE STUDY.
Exclusion Criteria
  • The patient suffering from any severe systemic, or autoimmune disorders, specially those who are mentioned as Asadhya vyadhi as per clinical text of Ayurveda will be excluded.
  • Subjects having organic pathology of uterus and adnexa like Fibroid uterus,carcinoma of endometrium, endometriosis etc.
  • 1having pelvic inflammatory disease or 2chronic leucorrhoea.
  • 3Patients who vaccinated for covid19 with in past three month.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. NRS – Scale: Numeric Rating Scale for Dysmenorrhoea60 DAYS
Secondary Outcome Measures
NameTimeMethod
1. VMSS scale: Verbal Multidimensional Scoring System60 DAYS

Trial Locations

Locations (1)

NIA ( Deemed to be University) OPD and IPD, Jaipur

🇮🇳

Jaipur, RAJASTHAN, India

NIA ( Deemed to be University) OPD and IPD, Jaipur
🇮🇳Jaipur, RAJASTHAN, India
DR PREETI KUKRELE BAGDI
Principal investigator
9770313129
dr.preetibagdi@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.